Belatacept 	Cyclosporine	Mycophenolic acid exposure	1160	1266	The MPA exposure tended to be higher among belatacept patients than in CsA patients at week 1 (P = 0.057).
Belatacept 	Cyclosporine	Mycophenolic acid exposure	1160	1265	The MPA exposure tended to be higher among belatacept patients than in CsA patients at week 1 (P = 0.057)
